查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468010

关节内粘稠补充疗法市场：按产品、来源、应用和最终用途 - 全球预测 2024-2030

Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年关节内粘稠补充疗法市场规模为28.3亿美元，预计2024年将达30.1亿美元，2030年将达43.2亿美元，复合年增长率为6.19%。

关节内粘稠补充疗法是一种将透明质酸注射到关节（例如膝盖）的医疗程序，以缓解骨关节炎等疾病引起的疼痛。作为一种非手术治疗选择，关节内粘稠补充疗法旨在改善关节功能、减轻疼痛，并可能延迟关节重建手术。关节疾病和运动相关损伤的增加、更容易患这些疾病的老年人数量的增加以及对微创手术的日益偏好是市场成长的主要因素。然而，包括类固醇注射和非药物治疗在内的替代治疗方案的存在可能会阻碍市场的成长。然而，透明质酸配方和输送的技术进步以及医疗保健基础设施的改善预计将为开拓关节内粘稠补充疗法市场创造潜在机会。

主要市场统计
基准年[2023] 28.3亿美元
预测年份 [2024] 30.1亿美元
预测年份 [2030] 43.2亿美元
复合年增长率（%） 6.19%

产品采用三次注射方案来减轻骨关节炎患者的疼痛和改善活动能力的情况正在迅速增加。

5 次注射方案是一种关节内粘稠补充疗法，由 5 次透明质酸 (HA) 注射组成。此疗程通常每週进行一次，连续5週。它主要用于治疗膝骨关节炎，旨在恢復关节内滑液的润滑性和缓衝性能。单次注射方案提供了单次注射的便利，作为关节内粘稠补充疗法的替代方法。这些产品由高浓度的透明质酸配製而成，通常含有交联剂，可提高关节内治疗的耐久性和寿命。三次注射方案是一种广泛采用的关节内粘稠补充疗法，涉及一系列三次透明质酸注射。这些通常每週进行一次，旨在补偿关节间隙滑液的黏度。这种治疗的主要目标是减轻骨关节炎患者的疼痛并增加活动能力。三次注射方案在更广泛的五次注射疗程和单次注射治疗方案之间取得了平衡，在治疗承诺和症状缓解持续时间方面提供了中间位置。

对非动物性透明质酸的来源偏好增加，以消除过敏反应的风险

动物源性透明质酸是获得用于关节内粘稠补充疗法的透明质酸的主要资讯。动物源利用富含透明质酸的公鸡冠组织或从其他鸟类的组织中提取。非动物源性透明质酸是透过细菌发酵过程产生的。兽疫链球菌等基因工程菌株用于生物合成高纯度的透明质酸。非动物HA被认为是安全有效的，消除了与禽类蛋白相关的可能引起过敏反应的风险。此外，由于道德考量和生产一致性，非动物性透明质酸越来越受欢迎。

应用实例关节内粘稠补充疗法治疗膝骨关节炎的先进应用

手腕关节的关节内粘稠补充疗法包括将透明质酸直接注射到受影响的关节中。当传统的非手术治疗（例如止痛药和物理治疗）不够有效时，可以使用这种治疗方法。关节内粘稠补充疗法手腕关节的主要好处在于减轻疼痛，进而改善功能和生活品质。关节内粘稠补充疗法已被证明是治疗方法，特别是那些对传统治疗方法没有反应的患者。髋关节手术较为复杂，由于髋关节位置较深，通常需要超音波或 X 光导引。与长期使用非类固醇消炎剂（NSAID）相比，关节内粘稠补充疗法髋骨关节炎的主要优点是其安全性更高。膝骨关节炎最常使用的是关节内粘稠补充疗法。由于膝关节是主要的负重关节，因此非常容易磨损。关节内粘稠补充疗法程序旨在恢復因膝骨关节炎而损失的滑液的自然特性。

扩大关节内粘稠补充疗法在最终整形外科诊所/门诊手术中心 (ASC) 中的使用

医院是关节内粘稠补充疗法内替代疗法是骨关节炎（尤其是膝关节）患者的一种治疗选择。医院作为采用多学科方法的综合医疗机构，对于提供这种微创手术至关重要。关节内粘稠补充疗法包括将透明质酸注射到关节中以润滑关节、缓解疼痛并改善活动能力。整形外科诊所和门诊手术中心 (ASC) 是经常进行关节内粘稠补充疗法的特殊最终使用环境。由于这些中心专注于肌肉骨骼健康，因此非常适合提供关节内粘稠补充疗法等针对性治疗。 ASC 的便利性、效率和普遍较低的成本使其成为寻求门诊治疗的患者的有吸引力的选择。

区域洞察

由于骨关节炎盛行率不断上升、医疗保健成本不断上升、人们对微创治疗的偏好增加以及 FDA 批准的 HA 产品的普及，美洲市场正在不断发展。先进的医疗保健系统、对骨关节炎治疗选择的认识不断提高以及支持性法律规范正在推动欧洲关节内粘稠补充疗法市场的成长。由于治疗方法的可用性和可负担性的提高以及骨关节炎竞争性治疗方法的普及，中东和非洲的关节内粘稠补充疗法市场正在不断增长。由于骨关节炎的高发生率、不断扩大的医疗基础设施以及越来越多的先进骨关节炎治疗方法，亚太地区对关节内粘稠补充疗法的需求很高。此外，提高关节内粘稠补充疗法疗效的持续研究预计将推动全球对关节内粘稠补充疗法市场的需求。

FPNV定位矩阵

FPNV定位矩阵对于评估关节内粘稠补充疗法市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对关节关节内粘稠补充疗法市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.关节内粘稠补充疗法市场的市场规模与预测为何？

2.在关节内粘稠补充疗法市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.关节内粘稠补充疗法市场的技术趋势和法规结构是什么？

4.关节内粘稠补充疗法市场主要供应商的市场占有率为何？

5. 进入关节内粘稠补充疗法市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 骨关节炎非手术治疗的需求不断增加
      • 饮食习惯的改变导致文明病的发生率增加
      • 世界老年人口和肥胖症迅速增加
    • 抑制因素
      • 透明质酸治疗的副作用和高成本
    • 机会
      • 基于透明质酸的治疗方法的开发不断取得进展
      • 扩大关节内粘稠补充疗法在髌骨软骨病变中的作用
    • 任务
      • 核准严格、润滑镇痛持续时间短的监理要求
  • 市场区隔分析
    • 产品：三重註射疗法的采用激增，以减轻骨关节炎患者的疼痛并增加活动能力
    • 资料来源：越来越偏好非动物性透明质酸，以消除过敏反应的风险
    • 应用：关节内粘稠补充疗法治疗膝骨关节炎的应用进展
    • 最终用途：扩大关节内粘稠补充疗法在整形外科诊所/门诊手术中心（ASC）的使用
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章关节内粘稠补充疗法市场：依产品

  • 5次注射
  • 单次注射
  • 3次注射

第七章关节内粘稠补充疗法市场：依来源分类

  • 动物
  • 非动物的

第八章关节内粘稠补充疗法市场：依应用分类

  • 手骨关节炎
  • 髋骨关节炎
  • 膝骨关节炎

第九章关节内粘稠补充疗法市场：依最终用途分类

  • 医院
  • 整形外科诊所/门诊手术中心 (ASC)

第十章北美和南美关节内粘稠补充疗法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太关节关节内粘稠补充疗法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲关节内粘稠补充疗法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • KiOmed Pharma 和 Arsylab 宣布建立战略合作伙伴关係，在法国促销和分销 KioMedinevsone，这是一种治疗难治性膝骨关节炎的新疗法
    • Anika 的 Shingal 在 3 期试验中达到主要终点

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-0315DDADCE1F

[184 Pages Report] The Viscosupplementation Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.01 billion in 2024, at a CAGR 6.19% to reach USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into a joint, such as the knee, to relieve pain caused by conditions such as osteoarthritis. As a non-surgical treatment option, viscosupplementation aims to improve joint function, reduce pain, and possibly delay joint replacement surgery. Increasing incidences of joint disorders and sport-related injuries, a growing elderly population that is more susceptible to such ailments, and the rising preference for minimally invasive procedures significantly contribute to market growth. However, the existence of alternative treatment options, including steroid injections and non-pharmacologic therapies, may impede market growth. Nevertheless, technological advancements in formulating and delivering hyaluronic acid and healthcare infrastructure improvements are expected to create potential opportunities for developing the viscosupplementation market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.83 billion
Estimated Year [2024] USD 3.01 billion
Forecast Year [2030] USD 4.32 billion
CAGR (%) 6.19%

Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis

The five-injection regimen is a viscosupplementation treatment consisting of five hyaluronic acid (HA) injections. This course of therapy is typically administered once per week over five consecutive weeks. Primarily used for the management of knee osteoarthritis, this treatment aims to restore the lubricating and cushioning properties of the synovial fluid in the joint. The Single-Injection Regimen offers an alternative approach to viscosupplementation with the convenience of a one-time injection. This product is formulated with a high concentration of hyaluronic acid and often includes cross-linking agents that enhance the durability and longevity of the treatment within the joint. The Three-Injection Regimen is a widely adopted viscosupplementation treatment that involves a series of three hyaluronic acid injections. These are typically administered one week apart and are designed to supplement the viscous properties of synovial fluid in the joint space. The primary goal of this treatment is to relieve pain and enhance mobility in patients with osteoarthritis. The three-injection regimen strikes a balance between the more extensive five-injection course and the single-injection alternative, offering a middle ground in terms of treatment commitment and duration of symptom relief.

Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks

Animal-based sources have been the primary means of obtaining hyaluronic acid for viscosupplementation. Animal-based sources utilize tissues from rooster combs, which are rich in hyaluronic acid or are extracted from other avian tissues. Non-animal-based hyaluronic acid is produced through bacterial fermentation processes. Genetically modified strains of bacteria, such as Streptococcus zooepidemicus, are used to biosynthesize high-purity HA. Non-animal HA is considered safe and effective, eliminating the risks associated with avian proteins that can cause hypersensitivity reactions. Additionally, non-animal-based HA has been gaining popularity due to ethical considerations and consistency in production.

Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis

Hyaluronic acid is directly injected into the affected joint in the viscosupplementation treatment for hand osteoarthritis. This treatment is used when traditional non-surgical treatments such as pain medications and physical therapy have not provided adequate relief. The main benefit of viscosupplementation for hand osteoarthritis lies in its pain reduction and, hence, improvement in function and quality of life. Viscosupplementation is a proven therapeutic measure to alleviate pain and improve functionality in patients with hip osteoarthritis, particularly those not responding to conventional treatments. The procedure for the hip joint is more complex, often requiring ultrasound or X-ray guidance due to the hip's deep-seated nature. A key advantage of viscosupplementation in hip osteoarthritis is its superior safety profile compared to long-term use of non-steroidal anti-inflammatory drugs (NSAIDs). Knee osteoarthritis is the most common application for viscosupplementation since the knee is a major weight-bearing joint and, therefore, is highly susceptible to wear and tear. The viscosupplementation procedure aims to restore the natural properties of the synovial fluid lost to knee osteoarthritis.

End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)

Hospitals represent a significant end-use sector for viscosupplementation, a therapeutic option for patients suffering from osteoarthritis, particularly in the knee joint. As comprehensive medical facilities with a multidisciplinary approach, hospitals are pivotal in providing this minimally invasive procedure. Viscosupplementation involves the intra-articular injection of hyaluronic acid to lubricate the joint, alleviate pain, and improve mobility. Orthopedic clinics and Ambulatory Surgical Centers (ASCs) are specialized end-use settings where viscosupplementation is frequently administered. These centers are predominantly focused on musculoskeletal health, making them highly adept at providing targeted therapies like viscosupplementation. The convenience, efficiency, and typically lower costs associated with ASCs make them an attractive option for patients seeking outpatient care.

Regional Insights

The market is evolving in the Americas owing to the growing incidence of osteoarthritis, high healthcare expenditure, increasing preference for minimally invasive procedures, and widespread availability of several FDA-approved HA products. Advanced healthcare systems, increased awareness about osteoarthritis treatment options, and supportive regulatory frameworks are encouraging the growth of the viscosupplementation market in Europe. The Middle East and Africa viscosupplementation market is growing with improving availability and affordability of treatment and the prevalence of competitive treatment modalities for osteoarthritis. The Asia Pacific region represents significant demand for viscosupplementation due to high osteoarthritis prevalence, expanding healthcare infrastructure, and increasing accessibility to advanced osteoarthritis treatments. Besides, ongoing research to improve the efficacy of viscosupplementation therapy is anticipated to propel the demand for the viscosupplementation market globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Viscosupplementation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Viscosupplementation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., DePuy Synthes by Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Chem Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Five Injection
    • Single Injection
    • Three Injection
  • Source
    • Animal
    • Non-animal
  • Application
    • Hand Osteoarthritis
    • Hip Osteoarthritis
    • Knee Osteoarthritis
  • End-use
    • Hospitals
    • Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Viscosupplementation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Viscosupplementation Market?

3. What are the technology trends and regulatory frameworks in the Viscosupplementation Market?

4. What is the market share of the leading vendors in the Viscosupplementation Market?

5. Which modes and strategic moves are suitable for entering the Viscosupplementation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
      • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
      • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
      • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
    • 5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
    • 5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
    • 5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Viscosupplementation Market, by Product

  • 6.1. Introduction
  • 6.2. Five Injection
  • 6.3. Single Injection
  • 6.4. Three Injection

7. Viscosupplementation Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Non-animal

8. Viscosupplementation Market, by Application

  • 8.1. Introduction
  • 8.2. Hand Osteoarthritis
  • 8.3. Hip Osteoarthritis
  • 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viscosupplementation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
    • 13.3.2. Anika's Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030